Compare MRK & MBINN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | MRK | MBINN |
|---|---|---|
| Founded | 2000 | N/A |
| Country | United States | United States |
| Employees | N/A | 663 |
| Industry | Biotechnology: Pharmaceutical Preparations | Major Banks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 260.2B | N/A |
| IPO Year | N/A | N/A |
| Metric | MRK | MBINN |
|---|---|---|
| Price | $104.69 | $18.77 |
| Analyst Decision | Buy | |
| Analyst Count | 15 | 0 |
| Target Price | ★ $111.93 | N/A |
| AVG Volume (30 Days) | ★ 16.4M | N/A |
| Earning Date | 02-03-2026 | N/A |
| Dividend Yield | ★ 3.25% | N/A |
| EPS Growth | ★ 58.08 | N/A |
| EPS | ★ 7.56 | N/A |
| Revenue | ★ $64,235,000,000.00 | N/A |
| Revenue This Year | $1.97 | N/A |
| Revenue Next Year | $4.96 | N/A |
| P/E Ratio | $13.86 | ★ N/A |
| Revenue Growth | ★ 1.68 | N/A |
| 52 Week Low | $73.31 | N/A |
| 52 Week High | $105.84 | N/A |
| Indicator | MRK | MBINN |
|---|---|---|
| Relative Strength Index (RSI) | 67.21 | 34.08 |
| Support Level | $96.79 | $18.50 |
| Resistance Level | $100.94 | $19.20 |
| Average True Range (ATR) | 2.50 | 0.34 |
| MACD | 0.03 | 0.02 |
| Stochastic Oscillator | 92.18 | 35.46 |
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform, led by Keytruda, is a major contributor to overall sales. The company also has a substantial vaccine business aimed at preventing pediatric diseases, as well as Gardasil for human papillomavirus. Additionally, Merck sells animal health-related drugs. From a geographical perspective, 47% of the company's sales are generated from US human health (pharmaceuticals and vaccines).
Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.